Roos, Alison <br/><br/>
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.  [electronic resource] 

 -  British journal of cancer  Nov 2015 
 - 1289-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2015.305  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Bone Neoplasms--drug therapy<br/>Caspase 3--genetics<br/>Cell Line, Tumor<br/>Core Binding Factor Alpha 1 Subunit--genetics<br/>Doxorubicin--pharmacology<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Osteosarcoma--drug therapy<br/>Proto-Oncogene Proteins c-myc--genetics<br/>RNA, Small Interfering--genetics<br/>Transcriptional Activation--drug effects